mKRASvax Clinical Trials

1 actively recruiting trial across 1 location

Also known as: mutant KRAS peptide vaccine with Hiltonol® (Poly-ICLC)

Filter by location:

Baltimore, Maryland1 trial

Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.